91

Event

Emerging Topics in Health (EToH): Systems Immunity - "Investigating the impact of lymphatic transport from immune surveillance to metastasis"

Wednesday, January 25, 2023 15:30to16:30
McIntyre Medical Building Room 504, 3655 promenade Sir William Osler, Montreal, QC, H3G 1Y6, CA

On Wednesday January 25, Amanda W. Lund (Vilcek Institute of Graduate Biomedical Sciences New York University Grossman School of Medicine)will be giving a talk entitledInvestigating the impact of lymphatic transport from immune surveillance to metastasisas partof theEmerging Topics of Health (EToH) Seminar series, cohosted by the Departments of Microbiology and Immunology, Physiology and Human Genetics, the Goodman Cancer Institute (GCI) and the 91 Research Centre on Complex Traits (MRCCT).

Grad students: Sign up to have lunch with our guest speaker!

There will be a lunch with Dr Lund for graduate students and postdocs. If you would like to have lunch with our guest speaker, please fill out this.Thelunchwill be held from 12h to 1h in Room #530 in the Bellini.

Note: There will be a 5à7 after the talk at Brass Doors Pub (2171 Crescent Street) and anyone (students, postdocs, and faculty) are welcome to join!

You will find attached the poster. Here is her abstract:

The lymphatic vasculature is the critical interface between peripheral tissues and secondary lymphoid organs where adaptive immune responses are initiated. Though the immune response and the lymphatic vasculature are anatomically and functionally related, the contribution of these vessels to peripheral tissue and anti-tumor immunity remains underappreciated and unexplored. The Lund Lab tests the hypothesis that the lymphatic vasculature is an active regulator of cutaneous and tumor immunity both serving as the requisite route for immune priming and directly contributing to multiple mechanisms of immune resolution and tumor immune escape. By elucidating novel mechanisms of lymphatic vessel-mediated immune control we are working towards the long-term goal of identifying novel targets and strategies to use the lymphatic vasculature to tune immune function to enhance cancer immunotherapy

Thank you on behalf of the organizing committee of the EToH

Back to top